China’s Central Government To Invest $17 Billion In Healthcare Reform In 2009
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's Central government announced it would invest RMB 118.1 billion ($17.3 billion) for healthcare reform in 2009 during a joint working meeting April 20 with the National Development and Reform Committee, the Ministry of Health, the Ministry Of Finance, the Ministry of Human Resources and Social Security and the State FDA
You may also be interested in...
PharmAsia News' Top Industry Trends Of 2009
As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010
PharmAsia News' Top Industry Trends Of 2009
As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010
China’s Essential Drug System Expected To Consolidate Generic Industry, Promote Innovative R&D
One-third of small generic drug makers will be filtered out of the market in the next three to five years by the implementation of the new system, market research firm estimates.